Business news
The latest business news from across the chemistry-using industries, including mergers and acquisitions, legal and patent disputes, regulation and commercial performance, from the Royal Society of Chemistry's magazine, Chemistry World
-
-
BusinessTwo more European crackers to close
Sabic will not reopen UK plant and Dow will close another in Germany
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
OpinionGetting good at human tasks
’What do you mean you had to lock the NMR with an oscilloscope and shim the magnet by hand?’
-
BusinessFatal explosion and fire at Indian pharmaceutical ingredients plant
At least 42 dead and 25 injured at Sigachi Industries near Hyderabad
-
Business11 executives jailed over Italian PFAS pollution
Convictions relate to groundwater contamination around Miteni fluorochemicals plant
-
BusinessUS approves twice yearly injection to prevent HIV
Yeztugo (lenacapavir) provided near-total protection against infection in clinical trials
-
BusinessUK industrial strategy prioritises advanced manufacturing and life sciences
Government will subsidise electricity-intensive industries as part of support for eight key sectors
-
OpinionCritical metals supply strained
Conflict - both military and political - is having profound effects on supplies of a wide range of materials
-
OpinionThe future of oil refining in the UK
Can plants adapt to be compatible with a lower-carbon environment?
-
BusinessMilitary demand strains metal supply chains
Conflict and trade disputes have disrupted global supplies of specialist metals like hafnium, antimony and rare earths
-
BusinessCongo’s cobalt conundrum
DRC government is intervening to revive prices and stabilise supply chains
-
BusinessRNA as a replacement for chemical pesticides
Argentinian start-up Apolo Biotech is teaching plants to fight infections
-
BusinessUS plans to close Chemical Safety Board by October
Government says CSB duplicates capabilities in other agencies
-
BusinessSanofi to buy Blueprint Medicines for over $9 billion
Blueprint has one approved drug and enhances Sanofi’s immunology portfolio
-
OpinionSafety is everyone’s responsibility
Maintaining culture and investment is key, especially in the absence of incidents
-
BusinessExplosion and fire at Chinese chemical plant kills five
Six others missing and 19 injured at Shandong Youdao Chemical
-
OpinionIgnoring women’s health shouldn’t be an option
Developing therapies for conditions that predominantly affect women is a neglected, but enormous, opportunity
-
OpinionWomen are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
BusinessTrade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns